PixCell Medical
Portable Medical Diagnostic Products for Point-of-care Testing
Company Overview
Snapshot
Founded in June 2008 by Avishay Bransky, PixCell Medical operates with 51–200 employees. The company raised a total of $7.5M across 6 funding rounds and was acquired by Soulbrain Holdings in May 2021.
Business overview
PixCell Medical develops portable medical diagnostic products for point-of-care testing, primarily focusing on complete blood count (CBC) tests. Its core product, the HemoScreen hematology analyzer, provides lab-quality precision with a small, simple diagnostic device, delivering fast and accurate analysis for five-part differential CBC tests using a single drop of blood. The HemoScreen offers insights on 20 standard blood count parameters and comprehensive abnormal cell flagging, enhancing accessibility to CBC testing and reducing diagnostic turnaround time. Utilizing patented Viscoelastic Focusing technology and AI-powered machine-vision technology, PixCell Medical aims to enable earlier detection of complex diseases such as leukemia, lymphoma, and other cancers and infections, serving the healthcare and life sciences sectors, including providers and patients.
Strategic signal
In November 2022, PixCell Medical's HemoScreen hematology analyzer demonstrated superior performance in flagging abnormal white blood cells compared to the Sysmex XN, a leading lab hematology analyzer. This peer-reviewed validation underscores the HemoScreen's potential to significantly advance point-of-care diagnostics, offering a high-accuracy, rapid solution that can improve patient outcomes by enabling faster and more reliable detection of critical health conditions outside traditional laboratory settings.
Log in to access full profile ›Company Intelligence Q&A
- What is PixCell Medical's primary product?
- PixCell Medical's primary product is the HemoScreen hematology analyzer, a portable device designed for point-of-care complete blood count (CBC) tests.
- When was PixCell Medical acquired?
- PixCell Medical was acquired by Soulbrain Holdings in May 2021.
- What technology does PixCell Medical utilize in its diagnostic devices?
- PixCell Medical utilizes patented Viscoelastic Focusing technology and AI-powered machine-vision technology in its diagnostic devices to enable earlier detection of complex diseases.
- Did PixCell Medical receive any grants?
- In February 2022, PixCell Medical was awarded a grant by the International Health-Tech Pilot Program. In March 2018, the company received a grant from the European Commission.
- What was a significant partnership for PixCell Medical in 2022?
- In September 2022, PixCell Medical partnered with Insight Medical to distribute its HemoScreen hematology point-of-care analyzer in Papua New Guinea.